skip to Main Content

Dr. Tempero on Emerging Agents in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Margaret A. Tempero, MD, director, University of California, San Francisco (UCSF) Pancreas Center, professor of medicine, Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the interest in the pegylated hyaluronidase agent, PEGPH20, and clinical trials exploring other emerging agents in pancreatic cancer.
Watch here . . .

Back To Top